Filing Details

Accession Number:
0001181431-13-028416
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-16 17:38:25
Reporting Period:
2013-05-14
Filing Date:
2013-05-16
Accepted Time:
2013-05-16 17:38:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534287 Bioamber Inc. BIOA.U Industrial Organic Chemicals (2860) 980601045
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441261 Fcpr Vi Capital Sofinnova 17, Rue De Serene
Paris I0 75008
No No Yes No
1574139 Sas Partners Sofinnova 17, Rue De Serene
Paris I0 75008
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-14 880,000 $0.00 3,802,780 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2013-05-14 880,000 $10.00 440,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
880,000 2013-08-08 2017-05-09 No 4 P Direct
Footnotes
  1. In connection with BioAmber Inc.'s initial public offering, 880,000 units were purchased on 5/14/2013 at a price of $10.00 per unit. Each unit consists of one share of Common Stock and one warrant to purchase half of one share of Common Stock. The units currently trade on the NYSE. The Common Stock and warrants comprising the units will begin trading separately on June 10, 2013, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of Common Stock.
  2. Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.